市場調査レポート
商品コード
1410745
経カテーテル僧帽弁修復術(TMVR)の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年)Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経カテーテル僧帽弁修復術(TMVR)の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年) |
出版日: 2023年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
当レポートでは、世界の経カテーテル僧帽弁修復術(TMVR)市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。
市場モデルの主な内容は以下の通りです。
上市済みの経カテーテル僧帽弁修復術(TMVR)と進化する競合情勢
世界、地域、国レベルの市場固有の考察
医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。
対象企業
Not Applicable
Not Applicable
Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Repair (TMVR) market for the year 2020 and beyond. Transcatheter Mitral Valve Repair (TMVR) is currently FDA approved for non-surgical high risk degenerative mitral regurgitation. Mitral valve repair treatment is preferred over mitral valve replacement in patients who are eligible because it is linked with a lower short term and long term mortality and morbidity rates. Approximately, 50% of the severe mitral regurgitation patients are not eligible for surgery due to their age or other disorders. Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR).
Each of the covered 25 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable